Symmetry Partners’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-9,380
Closed -$222K 593
2021
Q4
$222K Buy
+9,380
New +$201K 0.01% 580
2021
Q2
Sell
-10,670
Closed -$227K 661
2021
Q1
$227K Sell
10,670
-138
-1% -$2.97K 0.02% 604
2020
Q4
$236K Buy
10,808
+55
+0.5% +$1.07K 0.02% 566
2020
Q3
$190K Buy
+10,753
New +$200K 0.02% 570
2020
Q2
Sell
-24,185
Closed -$418K 330
2020
Q1
$418K Sell
24,185
-7,347
-23% -$154K 0.09% 139
2019
Q4
$666K Hold
31,532
0.14% 102
2019
Q3
$617K Hold
31,532
0.13% 119
2019
Q2
$550K Hold
31,532
0.11% 144
2019
Q1
$584K Buy
31,532
+16,267
+107% +$290K 0.1% 128
2018
Q4
$245K Buy
+15,265
New +$241K 0.06% 212

Other funds holding MPT

Symmetry Partners's MPT Position: Q1 2022 in Review

Symmetry Partners sold out of Medical Properties Trust (MPT) in Q1 2022, closing a stake of 9,380 shares — an estimated $222K sold.

Symmetry Partners first reported a position in MPT in Q4 2018 and held it in 10 quarters. The position peaked at $666K in Q4 2019. 605 funds tracked by Wall St. Rank hold MPT as of Q1 2022.

  • Symmetry Partners reported no remaining Medical Properties Trust position as of Q1 2022 after selling out during the quarter.
  • Symmetry Partners sold 9,380 Medical Properties Trust shares in Q1 2022, an estimated $222K.
  • Symmetry Partners first reported a position in Medical Properties Trust in Q4 2018 and held it in 10 quarters.
  • Symmetry Partners's Medical Properties Trust position peaked at $666K in Q4 2019.
  • 605 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2022.

Based on Symmetry Partners's 13F filing for Q1 2022, filed 4 Apr 2022.